FARO ECONÓMICOSTOCK ANALYSIS

AXSM — analysis and forecast

$145.80-2.3% todayAxsome Therapeutics, Inc.
Verdict
Bearish
RSI (14)
51
MACD
▲ rising
Trend
Downtrend
Volatility
44%
52w range
13%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

76/ 100
Strong multibagger DNA

Strongest: Price vs. growth and Sales engine. Most lacking: Cash it generates and Faro seal.

Room to grow83

Worth $7.7 B. To grow ×10 it would have to reach $76.7 B.

Sales engine92

Sales +52% last quarter (year over year) and +66% last fiscal year.

Business quality85

Gross margin 93%, operating margin -19%, return on equity -176%.

Cash it generates24

Free cash flow −$24 M a year = -0.3% of its value (burning cash).

Price vs. growth93

Trades at 8.9× sales: 0.15 per point of growth (lower is better).

Balance sheet82

Net cash equal to 1% of its value.

Faro seal65

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 15.0%.

⏱️ Timing (not scored): near its 12-month low · below its 200-day average · trailing the S&P 500 by 4 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayBearish46%$145.91 +0.1%$141.94 – $149.98
3 daysBearish46%$146.13 +0.2%$139.32 – $153.27
1 weekBearish46%$146.35 +0.4%$137.61 – $155.65
15 daysBearish46%$146.91 +0.8%$134.65 – $160.29
1 monthBearish45%$148.15 +1.6%$130.57 – $168.09
3 monthsBearish47%$152.97 +4.9%$122.92 – $190.38

Recent momentum: -9.9% over 20 days · -33.2% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for AXSM. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 34 for $25 — included in Navigator and Admiral.

See all 34 reports →

❓ Frequently asked questions about AXSM

Could AXSM be the next NVIDIA?

Its Faro multibagger DNA is 76/100 (strong multibagger dna): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has AXSM gone up in the last year?

Axsome Therapeutics (AXSM) is up 4.4% over the last 12 months and trades at $145.80, 42.9% below its 52-week high ($255.17). 52-week range: $129.80 – $255.17.

How volatile is AXSM stock?

Its annualized volatility is around 44% and its worst drop from a peak over the last year was 49.1%. For reference, the S&P 500 usually moves 15–20% a year.

Does AXSM have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy AXSM?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: bearish technical bias, RSI 51, price below its 50-day average and an estimated 45% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.